JP2021534160A5 - - Google Patents
Info
- Publication number
- JP2021534160A5 JP2021534160A5 JP2021507740A JP2021507740A JP2021534160A5 JP 2021534160 A5 JP2021534160 A5 JP 2021534160A5 JP 2021507740 A JP2021507740 A JP 2021507740A JP 2021507740 A JP2021507740 A JP 2021507740A JP 2021534160 A5 JP2021534160 A5 JP 2021534160A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- riluzole
- vas
- reduces
- Prior art date
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023179961A JP2024010017A (ja) | 2018-08-16 | 2023-10-19 | 疾患処置のためのリルゾール口腔内崩壊錠の使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862764864P | 2018-08-16 | 2018-08-16 | |
| US62/764,864 | 2018-08-16 | ||
| PCT/US2019/046709 WO2020037152A1 (en) | 2018-08-16 | 2019-08-15 | Use of riluzole oral disintigrating tablets for treating diseases |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023179961A Division JP2024010017A (ja) | 2018-08-16 | 2023-10-19 | 疾患処置のためのリルゾール口腔内崩壊錠の使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021534160A JP2021534160A (ja) | 2021-12-09 |
| JPWO2020037152A5 JPWO2020037152A5 (https=) | 2022-03-02 |
| JP2021534160A5 true JP2021534160A5 (https=) | 2022-03-02 |
Family
ID=69525906
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021507740A Pending JP2021534160A (ja) | 2018-08-16 | 2019-08-15 | 疾患処置のためのリルゾール口腔内崩壊錠の使用 |
| JP2023179961A Pending JP2024010017A (ja) | 2018-08-16 | 2023-10-19 | 疾患処置のためのリルゾール口腔内崩壊錠の使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023179961A Pending JP2024010017A (ja) | 2018-08-16 | 2023-10-19 | 疾患処置のためのリルゾール口腔内崩壊錠の使用 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20210315865A1 (https=) |
| EP (1) | EP3836922B1 (https=) |
| JP (2) | JP2021534160A (https=) |
| KR (1) | KR20210045423A (https=) |
| CN (1) | CN112584831A (https=) |
| AU (1) | AU2019322889A1 (https=) |
| BR (1) | BR112021002692A2 (https=) |
| CA (1) | CA3109769A1 (https=) |
| EA (1) | EA202190544A1 (https=) |
| ES (1) | ES2987802T3 (https=) |
| IL (1) | IL280657A (https=) |
| MX (2) | MX2021001563A (https=) |
| PH (1) | PH12021550218A1 (https=) |
| SG (1) | SG11202100880VA (https=) |
| WO (1) | WO2020037152A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20230027189A (ko) * | 2020-06-24 | 2023-02-27 | 바이오하벤 테라퓨틱스 리미티드 | 강박 장애를 치료하기 위한 조성물 및 방법 |
| EP4240308A4 (en) * | 2020-10-05 | 2024-10-30 | Icahn School of Medicine at Mount Sinai | Riluzole for the treatment of alzheimer's disease |
| WO2022103638A1 (en) | 2020-11-16 | 2022-05-19 | Orcosa Inc. | Cannabinoids in the treatment of autism spectrum disorder |
| US11672761B2 (en) | 2020-11-16 | 2023-06-13 | Orcosa Inc. | Rapidly infusing platform and compositions for therapeutic treatment in humans |
| CN114177153B (zh) * | 2021-12-20 | 2023-04-07 | 平顶山市第二人民医院 | 一种利鲁唑口崩片及其制备方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1548022A (en) | 1976-10-06 | 1979-07-04 | Wyeth John & Brother Ltd | Pharmaceutial dosage forms |
| GB9908014D0 (en) | 1999-04-08 | 1999-06-02 | Scherer Corp R P | Pharmaceutical compositions |
| MXPA05005528A (es) * | 2002-11-26 | 2006-04-05 | Alk Abello As | Producto farmaceutico de alergeno. |
| US9241902B2 (en) * | 2003-12-17 | 2016-01-26 | R.P. Scherer Technologies, Llc | Chewable soft capsules containing ungelatinized starch |
| US8778979B2 (en) * | 2005-04-05 | 2014-07-15 | Yale University | Glutamate agents in the treatment of mental disorders |
| US20080260823A1 (en) * | 2007-04-20 | 2008-10-23 | Sciele Pharma, Inc. | Orally disintegrating tablet comprising glycopyrrolate for treating sialorrhea |
| PT2467372T (pt) * | 2009-08-10 | 2016-08-23 | Teva Pharma | Tratamento de distúrbios relacionados com bdnf usando laquinimod |
| US9041556B2 (en) | 2011-10-20 | 2015-05-26 | Apple Inc. | Method for locating a vehicle |
| US9434704B2 (en) * | 2012-05-08 | 2016-09-06 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological degenerative disorders |
| EA038518B1 (ru) * | 2014-11-21 | 2021-09-09 | Биохэйвен Фармасьютикал Холдинг Компани Лтд. | Сублингвальный препарат рилузола |
| MX2017006454A (es) * | 2014-11-21 | 2018-03-23 | Biohaven Pharm Holding Co Ltd | Administracion sublingual de riluzol. |
| WO2016085998A1 (en) * | 2014-11-26 | 2016-06-02 | Medicinova, Inc. | Combination of ibudilast and riluzole and methods of using same |
| RS62915B1 (sr) * | 2015-03-03 | 2022-03-31 | Biohaven Therapeutics Ltd | Prolekovi riluzola i njihova primena |
| JP2020506231A (ja) * | 2017-01-31 | 2020-02-27 | パオロ エル マンフレディ | 神経系の障害並びにその症状及び徴候の処置又は予防のため並びに疾患及び細胞の老化並びにその症状及び徴候に対する細胞保護のための化合物 |
-
2019
- 2019-08-15 WO PCT/US2019/046709 patent/WO2020037152A1/en not_active Ceased
- 2019-08-15 BR BR112021002692-4A patent/BR112021002692A2/pt not_active Application Discontinuation
- 2019-08-15 EA EA202190544A patent/EA202190544A1/ru unknown
- 2019-08-15 CA CA3109769A patent/CA3109769A1/en active Pending
- 2019-08-15 KR KR1020217007246A patent/KR20210045423A/ko not_active Ceased
- 2019-08-15 MX MX2021001563A patent/MX2021001563A/es unknown
- 2019-08-15 CN CN201980054201.0A patent/CN112584831A/zh active Pending
- 2019-08-15 JP JP2021507740A patent/JP2021534160A/ja active Pending
- 2019-08-15 US US17/268,072 patent/US20210315865A1/en active Pending
- 2019-08-15 ES ES19849456T patent/ES2987802T3/es active Active
- 2019-08-15 EP EP19849456.9A patent/EP3836922B1/en active Active
- 2019-08-15 SG SG11202100880VA patent/SG11202100880VA/en unknown
- 2019-08-15 AU AU2019322889A patent/AU2019322889A1/en not_active Abandoned
-
2021
- 2021-01-28 PH PH12021550218A patent/PH12021550218A1/en unknown
- 2021-02-04 IL IL280657A patent/IL280657A/en unknown
- 2021-02-08 MX MX2024007642A patent/MX2024007642A/es unknown
-
2023
- 2023-10-19 JP JP2023179961A patent/JP2024010017A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021534160A5 (https=) | ||
| JP2021063088A5 (https=) | ||
| ES2295009T3 (es) | Inhibidores de rho quinasa para la profilaxis y el tratamiento de neumonia intersticial y fibrosis pulmonar. | |
| JP2024133474A5 (https=) | ||
| JP2022191257A5 (https=) | ||
| JP2008501705A5 (https=) | ||
| JP5911929B2 (ja) | 特定の癌の治療のためのｒｄｅａ１１９／ｂａｙ８６９７６６を含む組み合わせ医薬 | |
| JP2006523216A5 (https=) | ||
| JP2009537550A5 (https=) | ||
| JP2010532768A5 (https=) | ||
| JP2019515884A5 (https=) | ||
| JP2021530543A5 (https=) | ||
| JP2006503850A5 (https=) | ||
| RU2018136580A (ru) | Цитратная соль (s)-4-((s)-3-фтор-3-(2-(5,6,7,8-тетрагидро-1,8-нафтиридин-2-ил)этил)пирролидин-1-ил)-3-(3-(2-метоксиэтокси)фенил)бутановой кислоты | |
| JP2015517523A5 (https=) | ||
| JP2023055858A (ja) | ５′－アデノシン二リン酸リボース（ａｄｐｒ）の使用方法 | |
| JP2011502131A5 (https=) | ||
| JP2023030113A5 (https=) | ||
| JP2022169780A5 (https=) | ||
| JP2025118775A5 (https=) | ||
| JP7665700B2 (ja) | 肝細胞癌の治療のための併用療法 | |
| JP2016537432A5 (https=) | ||
| JPWO2023089308A5 (https=) | ||
| JP2019531286A5 (https=) | ||
| TW201728328A (zh) | 針對具有重度腎功能障礙之癌症患者之治療方法 |